The first Grant Period of our COST Action Glioma MR Imaging 2.0 has drawn to a close. We can look back at a great start. Despite the Corona pandemic, which did indeed led to a very different end to our first Grant Period than was intended, many goals were achieved. Additionally, the website, newsletter, and social media accounts were launched – online tools that are more important than ever in creating and fostering our international community.
Planning of the coming grant period, which runs from May 2020 to April 2021, in the current situation is all but easy. However, we are working on ensuring that, also in these trying times, GliMR will succeed in bringing glioma researchers across Europe together.
In the meantime, we hope that all of you keep on participating in GliMR. Keep on working on those review papers, keep engaging with us via social media , and if you have any suggestions of (online) events to be organised do not hesitate to get in touch with your working group / WG5 / the leadership to see what can be arranged.
In collaboration with the organising committee of the annual meeting of the ESMRMB, we are planning our GliMR session during this virtual conference.
Meeting: Sept 30, 2020 – Oct 2, 2020
Abstract submission deadline: June 19, 2020 (23:59 CEST)
We are still organising our own Action meeting, currently planned for 4-6 February 2021 in Lisbon, Portugal, while keeping a close eye on the developments of the COVID-19 crisis.
GliMR reviews update
In our last newsflash, WG1 and WG3 called out to members interested in contributing to the writing of three reviews. More than 40 researchers reached out! Read more about this project here.
Short Term Scientific Missions (STSM)
Despite the current COVID-19 crisis, some of our STSM – Awardees were able to start their STSM. Here is what Ruben Nechifor, Golestan Karami, Fatemehsadat Arzanforoosh, and Burcu Alparslan had to say about their experience:
“I encourage any young researcher to consider STSM, because of the powerful results which could be obtained, and because STSM will also open further area of research and collaborations with various experts.” Dr Ruben Nechifor, STSM in Oxford, UK
“The STSM gave me a great opportunity to have scientific interaction and improve my knowledge in deep learning to obtain a new classification method for Glioma patients.” Ms Golestan Karami, STSM in Leiden, NL
“The STSM provided me a valuable learning opportunity, both on physiological analysis methods and coding knowledge within Quantiphyse to make widely applicable toolset for glioma.” Ms Fatemehsadat Arzanforoosh, STSM in Oxford, UK
“Thank you COST, for giving me the opportunity to meet extraordinary people in King’s College London, persevering with brain tumor research during these unprecedented times!” Dr Burcu Alparslan, STSM in London, UK
Deep Learning for Magnetic Resonance Imaging of Gliomas
Do you want to learn more about deep learning for MRI of gliomas? Prof. John Healy, Prof. Kathleen Curran, and Prof. Amira Šerifović-Trbalić have recently written the book chapter “Deep Learning for Magnetic Resonance Imaging of Gliomas”, in Deep Learning for Cancer Diagnosis, U. Kose, and J. Alzubi, eds, in press, Springer (2020).
Congratulations to our Researcher of the Month #2: Dr Paula Croal.
Don’t forget to nominate one of our colleagues for researcher of the month #3!
Paula Croal is a Postdoctoral Research Scientist at the University of Nottingham
With a background in neuroscience and physics, Paula’s research has focused on developing advanced methods for quantitative physiological imaging in disease, notably brain tumours and stroke, and bringing accessible software tools to the research community. She leads the development of the visualization and analysis tool Quantiphyse for clinical applications, including tumour imaging.
Recently recognised by The University of Nottingham’s Anne McLaren Fellowship as an ‘outstanding woman in STEM’, Paula will spend the next 3 years leading her own research program in Physiological MRI in brain tumours.
Take a photo of your puzzle and tag us (@COST18206) – we will share the most original ones!
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
This COST Action aims to build a pan-European and multidisciplinary network of international experts in glioma research, patient organisations, data scientists, and MR imaging scientists by uniting the glioma imaging community within Europe and progressing the development and application of advanced MR imaging for improved decision making in diagnosis, patient monitoring, and assessment of treatment response in clinical trials and clinical practice.